The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease. Pokorney SD, Granger CB. Circulation 2023;148:1455-1458.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pokorney SD, Granger CB. The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease. Circulation 2023;148:1455-1458.
PMID: 37931022